Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.
Clinuvel Pharmaceuticals Limited has announced a change in the start time of their Annual General Meeting (AGM) to 9:30am on the same scheduled date, 16 October 2024, at The Events Centre, Collins Square in Melbourne, due to venue availability issues. The company, known for its pioneering work in photomedicine and melanocortin peptides, develops treatments for a variety of serious disorders and has successfully commercialized SCENESSE®, a systemic photoprotective drug.
For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.
